DEFINITIVE PROXY STATEMENT

Company

Nuo Therapeutics, Inc.

Filed

May 2, 2014

Period of Report

June 9, 2014

Accession Number

0001144204-14-027233

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →